Rh isoimmunization following genetic amniocentesis.

Area of Science:

• Obstetrics and Gynecology
• Maternal-Fetal Medicine
• Immunology

Background:

• Rh isoimmunization is a significant risk in Rh-negative mothers with Rh-positive fetuses.
• Genetic amniocentesis is an invasive procedure that may pose a risk of feto-maternal hemorrhage.

Purpose of the Study:

• To evaluate the relationship between genetic amniocentesis and Rh isoimmunization.
• To assess changes in sensitization rates over time with procedural experience and technological advancements.

Main Methods:

• Retrospective examination of 8009 genetic amniocenteses.
• Analysis of Rh isoimmunization rates in 615 Rh-negative women at risk.
• Comparison of early program data with later data incorporating ultrasound guidance.

Main Results:

• Thirteen (2.1%) of the at-risk women developed Rh isoimmunization post-procedure.
• Most sensitizations (eleven) occurred early in the program.
• The risk of isoimmunization decreased significantly with accumulated experience and concurrent ultrasound use.

Conclusions:

• Genetic amniocentesis carries a risk of Rh isoimmunization, though historically low.
• Procedural experience and ultrasound guidance are critical in minimizing this risk.
• Current practices have reduced the risk to levels comparable with literature controls.